MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $753,000 | -22.2% | 90,000 | -26.5% | 0.58% | -8.9% |
Q4 2015 | $968,000 | +83.3% | 122,500 | +97.6% | 0.64% | +118.8% |
Q3 2015 | $528,000 | -40.7% | 62,009 | -13.9% | 0.29% | -58.6% |
Q2 2015 | $890,000 | +4.1% | 72,009 | 0.0% | 0.70% | -1.7% |
Q1 2015 | $855,000 | +5.0% | 72,009 | 0.0% | 0.72% | -10.9% |
Q4 2014 | $814,000 | – | 72,009 | – | 0.80% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lagoda Investment Management, L.P. | 775,571 | $2,389,000 | 0.93% |
KEMPNER CAPITAL MANAGEMENT INC. | 148,985 | $459,000 | 0.31% |
Yakira Capital Management, Inc. | 248,420 | $765,000 | 0.27% |
GARRISON BRADFORD & ASSOCIATES INC | 87,700 | $270,000 | 0.24% |
Cannell & Co. | 1,212,478 | $3,734,000 | 0.13% |
LeJeune Puetz Investment Counsel LLC | 3,976 | $180,000 | 0.13% |
ALPINE WOODS CAPITAL INVESTORS, LLC | 726,000 | $2,236,000 | 0.12% |
Virtus ETF Advisers LLC | 198,735 | $612,000 | 0.11% |
STONERIDGE INVESTMENT PARTNERS LLC | 199,227 | $614,000 | 0.08% |
Birchview Capital, LP | 44,000 | $136,000 | 0.08% |